| 6OE3: reference: Structural and pharmacological evaluation of a novel non-nucleoside reverse transcriptase inhibitor as a promising long acting nanoformulation for treating HIV., Kudalkar SN, Ullah I, Bertoletti N, Mandl HK, Cisneros JA, Beloor J, Chan AH, Quijano E, Saltzman WM, Jorgensen WL, Kumar P, Anderson KS, Antiviral Res. 2019 Apr 26;167:110-116. doi: 10.1016/j.antiviral.2019.04.010. PMID: 31034849 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).